ZBTB7A

Across TCGA pan-cancer cohorts, ZBTB7A mass-spec protein differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of ZBTB7A’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where ZBTB7A mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types ZBTB7A is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.

COAD, LSCC, and PDAC are the cancer types where ZBTB7A tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ZBTB7A mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	−0.162	<.001	9	view →
LSCC	Male	III,IV	+0.477	<.001	8	view →
PDAC	All	All	+0.387	<.001	7	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

ZBTB7A–COAD

Open the COAD breakdown →